Stocks lower, oil surges, Bristol Myers-Mirati, UAW strikes, Disney
The deadliest attacks on Israel in at least five decades has sent oil prices surging and puts global markets on edge heading into a key week on Wall Street.Iran's links to Hamas and Hezbollah, the groups responsible for the deadliest attacks on Israel in decades, has sent global oil prices surging over concerns of a region-wide conflict.Bristol Myers will pay up to $5.
8 billion for cancer treatment specialists Mirati Therapeutics in the last oncology deal in the fast-moving pharma sector.The United Autoworkers Union, which is entering its fourth week of strike action against the Big 3 automakers, rejected a tentative pay deal with Volvo-owned Mack Trucks late Sunday.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Mirati Stock Falls as Bristol Myers to Buy Oncology Developer for Up to $5.8 BillionThe acquisition will help boost revenue by offsetting upcoming competition from generics for Bristol Myers Squibb’s best-selling products.
Read more »
Bristol-Myers Squibb shells out $5.8B for Mirati: 5 big deal reportsBristol-Myers Squibb shells out $5.8B for Mirati: 5 big deal reports
Read more »
Bristol-Myers Squibb to acquire Mirati in $5.8 billion dealBristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion.
Read more »
Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Read more »
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Read more »
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionMirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...
Read more »